Tower Research Capital LLC (Trc) Surrozen, Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.44 - $0.89 $137 - $278	313 Added 3.72%	8,738 $4,000
Q2 2023 Aug 14, 2023	SELL	$0.55 - $0.72 $4,819 - $6,309	-8,763 Reduced 50.98%	8,425 $4,000
Q1 2023 May 09, 2023	BUY	$0.56 - $1.32 $3,652 - $8,610	6,523 Added 61.16%	17,188 $10,000
Q4 2022 Feb 10, 2023	BUY	$0.42 - $2.01 $4,239 - $20,286	10,093 Added 1764.51%	10,665 $6,000
Q3 2022 Nov 10, 2022	BUY	$0.26 - $3.53 $148 - $2,019	572 New	572 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.14 - $3.43 $4,971 - $7,967	-2,323 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.2 - $6.01 $5,110 - $13,961	2,323 New	2,323 $7,000

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $342M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.